Vanderbilt-Emory-Cornell-Duke Consortium for Global Health Fellows (VECDor)

项目总结 范德比尔特-埃默里-康奈尔-杜克财团(VECDor)带来了实质性和互补性的专业知识 有经验的机构加入福格蒂全球健康研究员计划。范德比尔特全球研究所 健康(VIGH)曾担任Fogarty国际临床研究学者和研究员(FICRS-F) 计划支持中心自2007年以来，与87个合作机构合作，培育了419个具有竞争力的入选机构 来自美国和27个中低收入国家(LMIC)的博士后和博士后培训生。主题 包括传染病、癌症、心脏病和肺病、中风、糖尿病、营养、行为和 精神健康问题(包括药物滥用)、妇女和儿童健康、眼科疾病、口腔 健康、神经学和动物-人类健康。VECDor经验丰富的全球健康导师已经 在美国和LMIC合作机构合作，被选为多样化的、资金充足的研究地点 非洲(肯尼亚、赞比亚、坦桑尼亚、卢旺达)、亚洲(印度、中国、越南)、拉丁美洲(巴西、墨西哥)、 和加勒比海(海地)。使用高效的支持中心，最大限度地将资金投向 研究培训，并利用多种财政和实物联合资金来源，我们将与更多 超过68个T32和其他由NIH资助的培训项目，并与少数族裔机构合作伙伴选择和 部署80至100名美国和LMIC受训人员，他们在研究职业生涯中有出色的前景。VECDor将 在整个财团范围内实施战略指导和学员支持计划，包括 实地部署前的准备阶段，并在研究年度结束后继续进行，以确保 最高质量的研究出版物和科学会议演示文稿，以及最大程度的实习生成功 获得研究和职业发展补助金。研究主题将涉及所有主题和 学员和NIH研究所和中心感兴趣的地理区域，强调可传播性 和非传染性疾病。我们将通过长期监测和记录该计划的影响 使用FIC的CareerTrac跟踪所有研究员的职业方向和产出的评估(M&E)计划 系统，例如，未来就业、K补助金、研究补助金、科学报告和出版物。我们会 进一步完善我们现有的基于网络的工具，以分享知识，促进本地和全球网络，以及 加强和维持全球卫生研究员和校友的临床研究技能。我们已经撮合了 大量的机构和现场联合资金，以利用NIH的资源。VECDor是建立在相互的 尊重我们的美国和全球合作伙伴，以及我们在研究、创新和指导方面的集体记录。 结合我们最近在研究培训计划管理方面的丰富经验，稳健的研究 具有全球意义的重大疾病资助基地，著名的国际研究培训伙伴和 网站，以及增强的机构共同出资承诺，VECDor将继续培养 21世纪的全球卫生研究队伍，就像我们在现有的FICRS-F计划中所做的那样。

PROJECT SUMMARY The Vanderbilt-Emory-Cornell-Duke Consortium (VECDor) brings the substantial and complementary expertise of experienced institutions to the Fogarty Global Health Fellows Program. The Vanderbilt Institute for Global Health (VIGH) has served as the Fogarty International Clinical Research Scholars and Fellows (FICRS-F) Program Support Center since 2007, working with 87 partner institutions to nurture 419 competitively chosen pre- and postdoctoral trainees from the US and from 27 low- and middle-income countries (LMICs). Topics have included infectious diseases, cancer, heart and lung disease, stroke, diabetes, nutrition, behavioral and mental health issues (including substance abuse), women's and children's health, ophthalmic disease, oral health, neurology, and animal-human health. VECDor's highly experienced global health mentors are already working together in the US and LMIC partner institutions, selected as diverse, well-funded research sites in Africa (Kenya, Zambia, Tanzania, Rwanda), Asia (India, China, Vietnam), Latin America (Brazil, Mexico), and the Caribbean (Haiti). Using a highly efficient support center that maximizes the direction of funds to research training, and leveraging multiple sources of financial and in-kind co-funding, we will link with more than 68 T32 and other NIH-funded training programs and with minority institution partners to select and deploy 80 to 100 US and LMIC trainees with outstanding promise for research careers. VECDor will implement a strategic mentoring and trainee support plan across the consortium, including a substantial preparation phase prior to field deployment and continuing after the research year is completed, to ensure the highest quality research publications and scientific meeting presentations, and maximum trainee success in obtaining research and career development grants. Research themes will address all topic and geographical areas of interest to trainees and NIH Institutes and Centers, emphasizing both communicable and non-communicable diseases. We will document the Program's impact through a long-term monitoring and evaluation (M&E) plan that tracks the career directions and outputs of all Fellows, using FIC's CareerTrac system, e.g., future employment, K grants, research grants, scientific presentations, and publications. We will further refine our existing web-based tools to share knowledge, foster local and global networking, and strengthen and sustain clinical research skills among global health fellows and alumni. We have brokered substantial institutional and site-based co-funding to leverage NIH resources. VECDor is built on the mutual respect of our US and global partners and our collective track record of research innovation and mentorship. Combining our extensive recent experience in research training program management, robust research funding bases in major diseases of global significance, renowned international research training partners and sites, and enhanced institutional co-funding commitments, VECDor will continue to nurture key members of the global health research workforce of the 21st century, as we have done within the incumbent FICRS-F program.